Status unknownNCT03618615APIAUpdated Sep 12, 2018

Anatomical Study of the Arteries of the Skin on Amputation Legs

An observational study in Arteritic Leg Ulcer, sponsored by Central Hospital, Nancy, France. Status unknown. Open to participants aged 18 Years to 95 Years. Per ClinicalTrials.gov, last updated 2018-09-12.

Sponsored by Central Hospital, Nancy, France · Observational

The sponsor has not verified this record recently (last verified Sep 2018), so the status shown — last known as Not yet recruiting — may be out of date.

Study type: Observational
Model: Cohort
Time perspective: Prospective
Enrollment: 100
Ages: 18 Years to 95 Years
Sex: All

Study summary

PRIMARY OBJECTIVE Qualitatively describe the distribution of cutaneous arteries in patients with long-term occlusive arterial disease.

SECONDARY OBJECTIVE To compare the distribution of cutaneous arteries observed on the legs of arteritic patients with that observed on non-arteritic legs (from bodies given to science).

Read the detailed description

Arterial patient coming to CHRU Nancy, in the Vascular and Endoluminal Surgery Department, to undergo leg amputation.

Usually, after the amputation of the leg in the operating theatre, the surgical waste is destroyed.

Instead of being destroyed, the leg will be used for research.

Conditions studied

Arteritic Leg Ulcer

Browse trials for

Leg Ulcer 298

In context

Leg Ulcer

298 studies on the registry are indexed under Leg Ulcer; 43 are open to participants now.

This study's planned enrollment of 100 is close to the median of 100 across 40 observational studies indexed under Leg Ulcer.

Browse Leg Ulcer studies →

Lead sponsor

Central Hospital, Nancy, France is the lead sponsor of 778 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 18 Years to 95 Years
Sexes eligible: All
Accepts healthy volunteers: No
Sampling method: Probability sample

Study population

arteritic patient coming to CHRUN as part of the care

Inclusion criteria

Major Patient
Patient with late stage occlusive arteriopathy with lower limb amputation
Patient who did not oppose the search
Patient affiliated to a social security scheme

Exclusion criteria

Exclusion Criteria:

Patients with infectious diseases not accessible in the anatomy laboratory
Woman of childbearing age without effective contraception
Persons referred to in Articles L. 1121-5 to L. 1121-8 and L1122-2 of the Public Health Code :
Pregnant woman, parturient or nursing mother
Person deprived of liberty by a judicial or administrative decision,
Person under psychiatric care pursuant to Articles L.3212-1 and L.3213-1 of the Public Health Code
Person admitted to a health or social institution for purposes other than research
Minor person (not emancipated)
Adult subject to a legal protection measure (guardianship, trusteeship, protection of justice)
Major person who is not in a position to express consent and who is not subject to a legal protection measure

Study design

Observational model: Cohort
Time perspective: Prospective
Enrollment: 100 participants (estimated)
Patient registry: No
Biospecimen retention: Samples without dna

Interventions

Biologicalartericitc surgery
biological sample (leg) from leg amputation surgery used for research

What researchers measure

Primary outcomes

Qualitative mapping of the skin's arteries.
The leg will be transported in a container to the Anatomy Laboratory (Faculty of Medicine - University of Lorraine). Within 72 hours of its arrival, the operating room will be dissected to qualitatively describe the distribution of cutaneous arteries in patients with long-term occlusive arterial disease.
Time frame: 72 hours after the dissection of the leg.

Study locations

No study locations are listed for this record.

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Sep 12, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT03618615
Lead sponsor: Central Hospital, Nancy, France
Responsible party: Sponsor
First posted: Aug 7, 2018
Start date: Sep 30, 2018 (estimated)
Primary completion: Sep 30, 2021 (estimated)
Completion: Sep 30, 2021 (estimated)
Last update: Sep 12, 2018

Oversight

FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Leg Ulcer→

Other studies from this sponsor

Central Hospital, Nancy, France

Start the discussion